When antibody levels detected in recovered COVID-19 patients were stratified by time after onset of symptoms (<6 weeks, 6–8 weeks, and >8 weeks), IgM levels gradually declined, while IgG and IgA levels remained significantly higher among patients with pneumonia (S4, S5, and S6 Tables). This evidence concerns the gene CD40LG and susceptibility to pneumonia measurement.